Treatment of psychomotor agitation and self-injurious behavior with estrogen and progesterone in a patient with Sanfilippo syndrome [1]

General Hospital Psychiatry

Volumn 27, Issue 4, 2005, Pages 298-300

  Kushner, Steven A ^a   Guze, Barry H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ANAMNESIS; AUTOMUTILATION; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; LABORATORY TEST; LETTER; RESTLESSNESS; SANFILIPPO SYNDROME; SLEEP DISORDER;

ADULT; ESTROGENS; FEMALE; HUMANS; MUCOPOLYSACCHARIDOSIS III; PROGESTERONE; PSYCHOMOTOR AGITATION; SELF-INJURIOUS BEHAVIOR; UNITED STATES;

EID: 21244479705     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2005.02.005     Document Type: Letter

References (27)

1. B.H. King, C. DeAntonio, J.T. McCracken, S.R. Forness, and V. Ackerland Psychiatric consultation in severe and profound mental retardation Am J Psychiatry 151 1994 1802 1808
2. Madrid AL, State MW, King BH. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation. Child Adolesc Psychiatr Clin N Am 2000;9:225-43, x-xi.
3. J.M. Ryan Pharmacologic approach to aggression in neuropsychiatric disorders Semin Clin Neuropsychiatry 5 2000 238 249
4. D.V. Taylor, D. Rush, W.P. Hetrick, and C.A. Sandman Self-injurious behavior within the menstrual cycle of women with mental retardation Am J Ment Retard 97 1993 659 664
5. E.H. Quint, T.E. Elkins, C.A. Sorg, and S. Kope The treatment of cyclical behavioral changes in women with mental disabilities J Pediatr Adolesc Gynecol 12 1999 139 142
6. E.G. Carr, C.E. Smith, T.A. Giacin, B.M. Whelan, and J. Pancari Menstrual discomfort as a biological setting event for severe problem behavior: assessment and intervention Am J Ment Retard 108 2003 117 133
7. D.L. Keefe Sex hormones and neural mechanisms Arch Sex Behav 31 2002 401 403
8. G. Yogalingam, and J.J. Hopwood Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: diagnostic, clinical, and biological implications Hum Mutat 18 2001 264 281
9. R. Barone, F. Nigro, and F. Triulzi Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome) Neuropediatrics 30 1999 270 274
10. M.C. Bax, and G.A. Colville Behaviour in mucopolysaccharide disorders Arch Dis Child 73 1995 77 81
11. D.B. Hier, S. Ahluwalie, M. Melyn, and G.E. Hoganson Jr. Estrogens control aggressive behavior in some patients with Sanfilippo syndrome Neurol Res 21 1999 611 612
12. D.B. Petitti Clinical practice. Combination estrogen-progestin oral contraceptives N Engl J Med 349 2003 1443 1450
13. C.N. Rudick, and C.S. Woolley Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat J Neurosci 21 2001 6532 6543
14. B. McEwen Estrogen actions throughout the brain Recent Prog Horm Res 57 2002 357 384
15. M.J. Kelly, J. Qiu, and O.K. Ronnekleiv Estrogen modulation of G-protein-coupled receptor activation of potassium channels in the central nervous system Ann N Y Acad Sci 1007 2003 6 16
16. J. Kulkarni, A. de Castella, and D. Smith A clinical trial of the effects of estrogen in acutely psychotic women Schizophr Res 20 1996 247 252
17. E. Kuppers, T. Ivanova, M. Karolczak, and C. Beyer Estrogen: a multifunctional messenger to nigrostriatal dopaminergic neurons J Neurocytol 29 2000 375 385
18. M.A. Rettenbacher, S. Mechtcheriakov, A. Bergant, A. Brugger, and W.W. Fleischhacker Improvement of psychosis during treatment with estrogen and progesterone in a patient with hypoestrogenemia J Clin Psychiatry 65 2004 275 277
19. H.H. Kyomen, K.W. Nobel, and J.Y. Wei The use of estrogen to decrease aggressive physical behavior in elderly men with dementia J Am Geriatr Soc 39 1991 1110 1112
20. H.H. Kyomen, A. Satlin, J. Hennen, and J.Y. Wei Estrogen therapy and aggressive behavior in elderly patients with moderate-to-severe dementia: results from a short-term, randomized, double-blind trial Am J Geriatr Psychiatry 7 1999 339 348
21. P.S. Shelton, and V.G. Brooks Estrogen for dementia-related aggression in elderly men Ann Pharmacother 33 1999 808 812
22. E.S. Arafat, J.T. Hargrove, and W.S. Maxson Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites Am J Obstet Gynecol 159 1988 1203 1209
23. D. Bitran, R.J. Hilvers, and C.K. Kellogg Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor Brain Res 561 1991 157 161
24. A.H. Soderpalm, S. Lindsey, R.H. Purdy, R. Hauger, and H. Wit de Administration of progesterone produces mild sedative-like effects in men and women Psychoneuroendocrinology 29 2004 339 354
25. B.M. Stell, S.G. Brickley, C.Y. Tang, M. Farrant, and I. Mody Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors Proc Natl Acad Sci U S A 100 2003 14439 14444
26. M.J. Smith, J.C. Keel, and B.D. Greenberg Menstrual cycle effects on cortical excitability Neurology 53 1999 2069 2072
27. S.S. Smith, Q.H. Gong, and F.C. Hsu GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid Nature 392 1998 926 930